These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31934720)

  • 1. IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease.
    Low LD; Lu L; Chan CY; Chen J; Yang HH; Yu H; Lee CGL; Ng KH; Yap HK
    Clin Sci (Lond); 2020 Jan; 134(2):225-237. PubMed ID: 31934720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia in Progressive Renal Failure Is Associated with Changes in Hepatic Heparan Sulfate - PCSK9 Interaction.
    Shrestha P; Adepu S; Vivès RR; Masri RE; Klooster A; Kaptein F; Dam W; Bakker SJL; van Goor H; van de Sluis B; van den Born J
    J Am Soc Nephrol; 2021 Jun; 32(6):1371-1388. PubMed ID: 33758009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8.
    Li R; Liu Y; Shi J; Yu Y; Lu H; Yu L; Liu Y; Zhang F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1124-1133. PubMed ID: 31054325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.
    Adorni MP; Cipollari E; Favari E; Zanotti I; Zimetti F; Corsini A; Ricci C; Bernini F; Ferri N
    Atherosclerosis; 2017 Jan; 256():1-6. PubMed ID: 27940374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.
    Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A
    Hepatology; 2008 Aug; 48(2):646-54. PubMed ID: 18666258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic HNF1 transcription factors control the induction of PCSK9 mediated by rosuvastatin in normolipidemic hamsters.
    Dong B; Singh AB; Shende VR; Liu J
    Int J Mol Med; 2017 Mar; 39(3):749-756. PubMed ID: 28204827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients.
    Takeyama Y; Uehara Y; Anan A; Morihara D; Yokoyama K; Takata K; Tanaka T; Irie M; Iwata K; Shakado S; Sohda T; Sakisaka S
    Med Mol Morphol; 2017 Dec; 50(4):227-237. PubMed ID: 28660384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.
    Rashid S; Curtis DE; Garuti R; Anderson NN; Bashmakov Y; Ho YK; Hammer RE; Moon YA; Horton JD
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5374-9. PubMed ID: 15805190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of PCSK9 gene expression and diminished level of LDL-receptor in rat liver as a potential cause of post-lipectomy hypercholesterolemia.
    Dettlaff-Pokora A; Sucajtys-Szulc E; Sledzinski T
    Mol Cell Biochem; 2019 May; 455(1-2):207-217. PubMed ID: 30483910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of activation of liver X receptor alpha on cardiac & hepatic ABCC10 and SLC17A5 drug transporters in hypercholesterolemic rat model.
    El-Ashmawy NE; Khedr NF; Sallam M; Nossier AI
    Biochem Biophys Res Commun; 2022 Jun; 610():133-139. PubMed ID: 35462094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.
    Carreras A; Pane LS; Nitsch R; Madeyski-Bengtson K; Porritt M; Akcakaya P; Taheri-Ghahfarokhi A; Ericson E; Bjursell M; Perez-Alcazar M; Seeliger F; Althage M; Knöll R; Hicks R; Mayr LM; Perkins R; Lindén D; Borén J; Bohlooly-Y M; Maresca M
    BMC Biol; 2019 Jan; 17(1):4. PubMed ID: 30646909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol.
    Hirayama T; Honda A; Matsuzaki Y; Miyazaki T; Ikegami T; Doy M; Xu G; Lea M; Salen G
    Hepatology; 2006 Sep; 44(3):602-11. PubMed ID: 16941710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mulberry Fruit Extract Promotes Serum HDL-Cholesterol Levels and Suppresses Hepatic microRNA-33 Expression in Rats Fed High Cholesterol/Cholic Acid Diet.
    Lee S; Lee MS; Chang E; Lee Y; Lee J; Kim J; Kim CT; Kim IH; Kim Y
    Nutrients; 2020 May; 12(5):. PubMed ID: 32455724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ overexpression regulates cholesterol metabolism in human L02 hepatocytes.
    Han T; Lv Y; Wang S; Hu T; Hong H; Fu Z
    J Pharmacol Sci; 2019 Jan; 139(1):1-8. PubMed ID: 30554802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.
    Yin K; You Y; Swier V; Tang L; Radwan MM; Pandya AN; Agrawal DK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2432-42. PubMed ID: 26381871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
    Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
    Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of liver Pcsk9 gene expression as a possible cause of hypercholesterolemia in experimental chronic renal failure.
    Sucajtys-Szulc E; Szolkiewicz M; Swierczynski J; Rutkowski B
    Mol Cell Biochem; 2016 Jan; 411(1-2):281-7. PubMed ID: 26481479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
    Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment.
    Kwakernaak AJ; Lambert G; Slagman MC; Waanders F; Laverman GD; Petrides F; Dikkeschei BD; Navis G; Dullaart RP
    Atherosclerosis; 2013 Feb; 226(2):459-65. PubMed ID: 23261172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.